Last updated on January 2020

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status (APPRISE)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinson's disease
  • Age: Between 46 - 83 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Able and willing to sign a written informed consent for study participation
  • Age 46 - 83 years at the time of consent (per PKG Indications for Use, see Technical Instructions Manual)
  • Responsive to dopaminergic medications

Exclusion Criteria:

  • Contraindication to increasing dopaminergic therapy, such as current or treated freezing gait, symptomatic postural hypotension, or bothersome hallucinations
  • Wheelchair bound or bedridden
  • Utilizing or planning advanced PD therapies (DBS, infusion, etc.)
  • History of delirium in the past year
  • In the investigator's or sponsor's opinion, subject has any unstable or clinically significant condition that would impair the participant's ability to comply with study requirements or interfere with interpretation of the study endpoints (e.g., subject able to complete PKG wear instructions per Patient Instruction Manual, or ability to comply with required study procedures and visit schedule)

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.